Drug Information Services (DIS)
!
AHFS Drug information McEvoy GK (201 (2014) 4) author: McEvoy (American Society of Health System; AHFS)
!"$!"% # &'()*+ &'()*+,*,*./,0 .- /,01% 12 % 1 ! !33
Update: 2018
Book structure & main content: Monograph !"#$%& AHFS Pharmacolo Pharmacologic gic – Therapeuti Therapeutic c classificatio classification n -Title -Title & Synonyms Synonyms - Use -Dosage -Dosage & Administra Administration tion - Cautions Cautions - Adverse Adverse effect effect - Precaution Precaution & Contraindi Contraindicatio cation n -Pharmaco -Pharmacology logy - Pharmacok Pharmacokineti inetic c -Chemistry -Chemistry & Stability Stability - Preparatio Preparations ns how to use:
'()# Index *#+,%&%-./01# *#+,%&%-./01#2+ 0 Trade name 3-45 Generic name
mental image: IPD Pharmacist
unique info: '78%9:05&;<+%=6 <+%=6 >&6 &?1 ?6 1 USA - &6'78%9:05&; B%<'C, "@D--& @D--& - ,%&%-.?@ 0?1A%1B-)B%<'C,
) )A 2+?1'14 >5A!%D&6 5A!%D&6'14 '14 G53%:05&; 5 3%:05&;<'@ <'@ A8B'!5K#0BF 8B'!5K#0BF5+ 5+ - -2B-2&/IJ%.%&=6 2 (LBB+% 2)M6MD%-B-) 6D%-B-)
Drug information handbook author:
Corbett AH., Dana WJ., WJ., Fuller MA., Gallagher Gallagher JC., Golembiewski Golembiewski JA., Gonzales JP. et al (Lexicomp)
Update:
25th ed (2016(2016-201 2017) 7) book structure & main content:
Drug monograph '-6+A$%& +A$%& generic name -Name -Contraindication -PK/PD -Pha -Pharm rmac acol olog ogic ic cate catego gory ry -War -Warni ning ng/P /Pre reca caut utio ions ns - Dosa Dosage ge -Use -Use - Adverse Adverse reacti reaction on - Adminis Administra tratio tion n - Pregnancy Pregnancy risk factor factor - Drug interaction interaction - Monitoring Monitoring Parameter Parameter - Breast feeding feeding consideratio consideration n - Mechanism Mechanism of action action - Dosage Dosage forms - preparation - extemporaneous preparation - stability how to use:
'()# index (#%13<" 0 A) '84 > '84 >53%'<:310%:5A+%=6 53%'<:310%:5A+%=6 > >,1?! ,1?! ('-6+A$%& +A$%& A-Z) L<2'() 0 #310%=6 310%=6 > > $5AD%0
mental image:
unique info: -,%&%-./01: ,%&%-./01:5&; 0 D) =6 >, J%/" %/"P:5A+%L$F P:5A+%L$F<9$" <9$"2 @ 4 >5D%-/0% 5D%-/0% - 4 Comprehensive Appendix
3
MIMS Thailand author: TIMs (Thailand)
update:
book structure & main content:
2016 (annual)
!" #$!"%&'()*+,*-./,0!"),9C!3() 3 ;(0,
Book structure: Thailand National List of Essential Medicine (NLEM) -> Pregnancy safety > how to use -> New in this issue -> MIMs classification index -> Abbreviation index -> Production information section -> Company directory -> Brand & generic index Main contents: Product information: (-9D5B#02+ -MIMs class -Brand name - Distributor -Content -Indication - dosage - pre/post pradial advice - Contraindication - special precaution - Adverse Reactions - drug interaction - presentation & packaging - US FDA pregnancy how to use: H >A'-6+A$%&DA'-6+A$%& Brand name L<9 generic name *#+=6 > generic - Brand & generic index Q name !9'(N1$"231"A , 45'56+A K&F& 6 ® mental image: Data from Drug company
4567892 #: ;<*9)$"+=1 # 13 >,;3 &+?709@;*A >6./5
unique info: -: 05&;<+%=6 >&?6 1(-9'=RK=+ -: 05&;
Pharmacotherapy (Dipiro) author: Joseph T. DiPiro Update: 10th ed (2016) book structure & main content: Contents: '-6+A$%&D'D)#:H G1D"B-9BB52"+29$F%AU?1-F%AD%+ K# 0'(N1 17 sections L<9 L$F<9 section !9L+D+F5+'(N1*-/$F%AU -2&L<02&6="AG 3 121 chapters *#+L$F<9*-/LBFA'14 G53%'(N1 Key concepts / Epidemiology / Etiology / Pathophysiology / Clinical presentation / Treatment / Evaluation of Therapeutic outcomes / Conclusion / Abbreviations / References Appendix: 5+; F="AG # 0%1310%L<9#0%13<"A:5A31"A , 45 *#+!95+; F3<"A(DL:NA B5D'D6 >+2D"B/F%E< $-2!=%A 3 05A(V)B$ " D) %- Index :5+; F=6 ># 0%13<"A:5A31"A , 45*#+!9'D6 >+2D"BD%--"DT%, @ 4 >5+%, @ 4 >5*-/ *#+'-6+A$%& 5"DT- A-Z how to use:
'()#$%& Index =6 >5+; F# 0%13<"A:5A31"A , 45 '-6+A$"25"DT-!%D A-Z
mental image: - Disease for hospital - Treatment
unique info:
&6D%-LBFA'14 G53%$%&D
Drug interaction facts author:
David S. Tatro
(Lippincott Williams & Wilkins)
update: 2015 ")@);D(9/09&.?29"7#:*+,*- E,0'?0?6? book structure & main content:
31"A , 45 Drug Interaction Facts !9&6 How to use *#+!95M)B%+, F21(-9D5B:5A31"A 4,5 L<9/%1)+%& :5A/%R "8=W$F%AU?131"A , 45 '@ F1 Drug interaction /4559K-, (-9'C=:5ADrug interaction &659K-B0%A, Rating -9#"B$F%AU3&%+.HA59K-, E<:5AD%-,;BBO3-6 >$F5D%-?@ 0+%(-9'C=$F%AU 5M)B%+/J%+F5=6 >&?6 131"A , 45 '(N1$01 4 >5+%?1D5D%-/0%, Monograph: (-9D5B#02+ D Interaction D"1 L<9+D$"25+F%A@ -9#"BSignificance, Onset, Severity, Documentation, Effect, Mechanism, Management Appendix: !9&6: 05&;<:5A+%L$F<9D
H >A5+; F# 0%13<"A:5A31"A , 45 Index !9'-6+A$"25"DT-!%D A-Z '()#3%+%!%D Index Q *#+!9L,#A'(N1 @ 4 >5+% 3-45 D'D)# Interaction L<9B5D-9#"B Significance
mental image:
unique info:
Drug interaction
-B5D-9#"BSignificance, Onset, Severity, Documentation, Effect, Mechanism, Management :5A/; F+%=6 > 'D)# Drug interaction D"1 6
Remington author:
Alfonso R Gennaro (20th ed) (Lippincott Williams & Wilkins; 20th ed) (Pharmaceutical Press; 22nd ed)
Update: 22nd ed (2013) book structure & main content:
31"A , 45LBFA'(N1 8 Parts #"A16 G Part1 Orientation /Part2 Pharmaceutics /Part3 Pharmaceutical chemistry/ Part4 Pharmaceutical testing Part5 Pharmaceutical manufacturing /Part6 Pharmacodynamics / Part7 Pharmaceutical and Medical agents Part8 Pharmacy practice how to use:
'()#$%& Index =6 >5+; F# 0%13<"A31"A , 45*#+'-6+A5"DT-!%D A-Z
mental image: Textbook in school of pharmacy contain all area in pharmacy
unique info:
'1 01 '14 G53%=%A'C, "@D--& 'C, "@'/&6 D%-2)'/-%93W=%A'C, "@D--& D%-E<)$+% ?1-;(LBB$F%AU L<95O(D-XW'/-4 >5A&45=6 > ?@ 0?1D%-E<)$ 7
Drug facts and comparison author: Borgsdorf LR, Cada DJ, Cirigliano M, et al. (Lippincott Williams & Wilkins) Update: 2017 (publication 2016)
!" #$!"%&'()*+,*-./,012 % 1 !3
book structure & main content: -Name - Contraindication -Indication - Warning/Precaution -Drug interaction - Action -Drug group comparison table & Dosage how to use:
- Patient information - Administation & Dosage - Overdosage
'()# index = 0%+'$ 05AD%-
mental image:
unique info: -&6$%-%A'(-6+B'=6+B+%?1L$F<9D
Martindale author: Brayfield, Alison (Pharmaceutical Press) Update: 39th Ed (2017)
!" #$!"%&'()*+,*-./,012 % 4 !3
book structure & main content: -Identification -Product availability -Precaution -Pharmacokinetic -Use & Administration how to use:
-Mechanism of action -Compatibility/Stability -Biopharmaceutical -ADR & Treatment
'-) >&'()#/01!%D General index
mental image:
unique info: - &6: 05&;<+%?1+O*-( - : 05&;<, F21(-9D5B54 >1U?1$J%-"B+% - Trade name/Generic name - L,#A,;$-*/-A,-0%A'/&6L<9 M.W. - D%-'DNB-"DT% - D%-<9<%+
9
Handbook on Injectable drug author:
American Society of Health-System Pharmacists
Update: 19th Ed (2016)
!" #$!"%&'()*+,*-./,012 % 2 !3
book structure & main content: 6 %-?@ 031"A , 45 *#+!95M)B%+/J%+F5$F%AU=6 >&?6 131"A , 45 -How to use ?1D%-L191J%2)MD -Monograph !95M)B%+'D6 >+2D"B+%76#1"1 G U '@ F1 Dose, pH, Trade name, 2)MD6 %-B-)3%-+%76# , Stability :5A+%76#, Solution Compatibility or Incompatibility, Additive Compatibility or Incompatibility , Drug in syringe compatibility, Y-site compatibility -Appendix !9&6: 05&;<'D6 >+2D"B Parenteral nutrition formulas HID reference , F2 150%A5)A:5A31"A , 45 how to use:
H >A5+; F# 0%13<"A:5A31"A , 45 Index !9'-6+A$"25"DT-!%D A-Z '()#3%+%76#!%D Index Q *#+!9&6=A"G @ 4 >5+% L<9 @ 4 >5D%-/0%
mental image:
unique info: -: 05&;<'D6 >+2D"B/2%&/A$"2:5A+%76# -$%-%A Solution Compatibility -$%-%A Additive Compatibility -$%-%A Drug in syringe compatibility -$%-%A Y-site compatibility 10
USP/NF book structure & main content:
United States Pharmacopeial Convention Update: 2017 (USP 40 NF 35)
author:
Volume 1: &6, F21:5A - General chapters ?3 0-%+<9'56+# tests L<9 assays $F%A U - Reagents, indicators L<9 solutions 'D6 >+2D"B/2%&3&%+
D%-'$-6+& :5A reagent $F%AU - Reference table '(N1$%-%A:5A/F%5 0%A5)A$F%A U '@ F1 atomic weight, solubility :5A,% H >A ?3 0 Volume 2-3: !9'(N1, F21:5A USP Monographs !9'(N1:05&;<-%+<9'56+#:5A,%-L$F<9@1)#Q : 05&;<: 05&;<84 G1Y%1 ( @ 4 >5,%&"P,*/-A,-0%A, ,;$-'/&6), definition, identification, assay, test , impurities, specificity test, additional requirement '@ F1 packaging & storage Volume 4: !9(-9D5B#02+ Dietary supplements monograph, Excipient L<9 NF monographs *#+=OD volume !9&6 general notice @ F2 A$01 5M)B%+ terms L<9=0%+'
'()# index = 0%+'
mental image:
unique info: -Monograph +% , F21(-9D5B+% ,%-'/&6
11
!
H >A'14 G53%!9'(N1D%-,-O(=6 >': 0%?!AF%+D2F% Index '-6+A$%& USP '(N1:5A5'&-)D% Q $"25"DT- L<9&6D%-LBFA'(N1 preparation $F%AU56D# 02+ &6Index 5+; F= 0%+=OD volume H >A?1 BP K&F&6 !HAL$D$F%A!%D BP &6: 05&;< isomeric ratio Q 3"2: 05 identification !9&63"2: 05 Test -2&5+; F# 02+ L$D$F%A!%D BP
!
H >A!9'14 G53%'+59&%DD2F% L<9$05A'()#$"2+F5$F%AU=6 >(-%DV?1 BP '(N1:5A5"ADZT Q monograph :5A+%L$F<9$"2'8) >& *#+$05A'()#=6 > appendix $F5 L<9 appendix H >A$ 05A'()#=6 > !9&65+; F=6 >'
H >A!9&65+; F=6 >'+ 2:05AD"B+%=" >2UK( Volumes III !9'D6 >+ 2:05AD"B82D+%-"A , 6 E<)$C"X[W!%D'<45# ,%-DF5C;&)/O 0&D"1 D%-EF%$"# Volumes IV (-9D5B#02+ Appendices, Infrared Reference Spectra L<9 Index Volumes V !9'D6 >+ 2:05AD"B+%, "$2W Volumes VI !9'(N1 CD-ROM version
!"
MEYLER's side effect of drugs author:
Jeffrey K. Aronson (Elsevier Science)
Update:
16th ed (2015)
book structure & main content: Contents LBFAD
H >A!9(-9D5B#02+ @ 4 >5+%?1D
H >A5A/W(-9D5B?1 monograph $%&=6 >D5+; F# 0%13<"A:5A31"A , 45'-6+A!%D A-Z &6 Index 2 -;(LBB /45 Index of Drugs L<9 Index of side effects :H G1D"B/IJ%/ 01=6 >$ 05AD%-3% mental image:
unique info:
: 05&;<'D6 >+2D"BD%-'D)# ADR 13
Drug in pregnancy and lactation author: Update:
Gerald G Briggs, et al. (Lippincott Williams & Wilkins) 11th Ed (2017)
book structure & main content: -Instruction for use *#+!95M)B%+, F21(-9D5B:5A31"A 4 ,5 L<9/IJ%1)+%&:5A/IJ%R "8=W$F%AU?1
31"A , 45
4 >5+%, D
how to use:
mental image:
H >A5+; F# 0%13<"A:5A31"A , 45 Index !9'-6+A$"25"DT-!%D A-Z '()#3%+%!%D Index Q *#+!9L,#A'(N1 @ 4 >5 Generic name unique info: -: 05&;<'D6 >+2D"B+%=6 >,%&%-.?@ 0?13P)A$"AG /--CW -: 05&;<'D6 >+2D"B+%=6 >,%&%-.?@ 0K# 0?13P)A
$"AG /--CW -,-O(5"1$-%+:5A+%=6 >'D)#D"B=%-D?1/--CW 4 > 1& -,-O(5"1$-%+:5A+%=6 >'D)#D"B=%-D=6 >#&
14
Physician desk reference author:
PDR staff (PDR network)
Update:
71st Ed (2017)
!" #$!"%&'()*+,*-./,012 % 1 !3
book structure & main content:
'(N1:05&;<=6 >K# 0!%DB-)T"=+% ?15'&-)D% ?1, F21:5A product information :5AL$F<9 product (-9D5B#02+ @ 4 >5D%-/0%, @ 4 >5,%&"P, (-9'C= +% Rx/OTC, highlight of prescribing information, recent major change, indications and usage, dosage and administration, contraindication, warning and precaution, adverse reaction, dosage form & strange, use in special population, over dose, clinical pharmacokinetic, nonclinical toxicology, clinical study, how supply & chandelling L<9 patient counseling information how to use:
&6 index # 0%1310% 2 index K# 0LDF 1. Manufacturers’s index L+D$%&B-)T"=+% 2. Brand and generic name index unique info:
mental image:
'(N 1 :05&;
15
Mosby's drug consult author:
Mosby (ELSEVIER)
Update: 5th Ed (2016)
book structure & main content: Main contents: Drug information: '14 G53%?116 G(-9D5B#02+ : 05&;<+%'B4 G5 A$01 '@ F1 D?@ 0?1'#ND), adverse reaction, Dosage & administration L<9 2)MD 6 %--"B(-9=%1 Herbal and supplement information: (-9D5B#02+ background, evidence, dosing, safety L<9 interaction how to use:
mental image:
1) , 4B/ 01: 05&;<+%!%D Brand name 3-45 DA&6 2) , 4B/ 01: 05&;<,&O1K8-!%D Herbal and supplement information Q appendix : 05&;< ,&O1K8-3-455%3%-',-)& ?30/ 01=6 >3<"A 310%(D Herbal and supplement information 3) Appedices: : 05&;<+%L$F<9D
: 05&;<,&O1K8- 5%3%-',-)&=6 >&D6 %-50%A5)A$%& 3<"D2)@%D%16
USP DI vol1 Author:
(Drug information for health care professional) U.S.Pharmacopeial Convention
Update:
27th ed (2007) !" #$!"%&'()*+,*-./,012 % 1 !3 !#77%$ #?,3 ;<*9) online book structure & main content:
?3 0: 05&;<'D6 >+2D"B+% ="AG prescriped drugs, OTC drugs L<9 Nutritional supplements L,#A'(N1 monograph L$F<9 monograph (-9D5B#02+ -title( @ 4 >5+%) - Category & indication(DFD"6G+$9@H06IB! 5 0 D@ ;!J ? most important information) -general dosing information L<9 oral dosage forms how to use:
'()# index # 0%13<"A ="AG (1) Indication index & (2) Genreral index (generic name L<9 brand name)
mental image: OPD Pharmacist - Counseling
unique info: - Prescriped drugs, OTC drugs L<9 Nutritional supplements - patient consultation - ?@ 0C%T%=6 >': 0%?!AF%+ - &6/IJ%.%&//J%$5B ?1-9#"B=6 >E; 0(F 2+!9.%& 17
USP DI vol2 Author:
(advice for the patient's drug information in lay language)
U.S.Pharmacopeial Convention
% 1 !3 !#77%$ #?,3 27th ed (2007)!" #$!"%&'()*+,*-./,012 ;<*9) online book structure & main content: Update:
Drug mono graph (-9D5B#02+ -Brand name in US/Canada- Description(Indication & dosage form) -Before using (Allergy/Pregnancy/Brest-feeding/childent/teenagers/older/other medicine/other medical problem), -Proper use (Recommendation for each dosage form/dose/missed dose/storage) -Precaution(while/after using) - Side effect - Additional information how to use:
1. / 013%:05&;<+%!%D index # 0%1310% '-6+A$%&$"25"DT- $%& generic name ('1 01$"231%) !%D1"1 G !9'-6+A$%& Brandname
mental image: OPD Pharmacist - Counseling
unique info: - Prescriped drugs, OTC drugs L<9 Nutritional supplements - patient consultation - ?@ 0C%T%=6 >': 0%?!AF%+ - &6/J%.%& //J%$5B ?1-9#"B=6 >E; 0(F 2+!9.%& 18
Handbook of nonprescription drugs author:
Daniel L. Krinsky, Stefanie P. Ferreri,et al.(APhA)
Update: 18th Ed (2015)
;:+,7 #:*+,*-!"),9C1%2 4 !3
book structure & main content: H >AL$F<9 Section !9LBFA'(N1*-/ 31"A , 45 Handbook of Nonprescription Drugs !9LBFA'(N1 Section Q ?1-9BB$F%AU L<9!9&6 Appendix I L<9 II Appendix I !9'D6 >+ 2:05AD"B Pregnancy and lactation ?@ 0,IJ%3-"B'<45D+% L<9 Nutritional supplement Appendix II !9'D6 >+ 2:05AD"B Botanical medication to avoid in Pregnancy and Lactation Monograph !9(-9D5B# 02+ Etiology, Pathophysiology, Sign and symptom, Treatment (&6 LE1E"A:"1G $51?1D%--"DT%), : 05/2--92"A:5A+%L$F<9@1)#, D%-'(-6+B'=6+B+%L$F<9$"2=6 >?@ 0?1D%--"DT% , $"25+F%A Case, D%-(-9'&)1E<<"8MW, Key-point =6 >, J%/"P how to use:
H >A5+; F# 0%13<"A:5A31"A , 45 Index !9'-6+A$"25"DT-!%D A-Z *#+!9 '()#3%+%!%D Index Q -2&D%--"DT%="AG Conventional L<9 Alternative therapy =6 >&?6 131"A , 45 $"25+F%A'@ F1 Aspirin, Acupuncture
mental image:
unique info: Disease for community pharmacy -: 05&;<'D6 >+2D"B*-/=6 >8B'!5?1-0%1+% -&6L12=%A?1D%-Q "D(-92"$/ ) 1K:0 -D%-'(-6+B'=6+B+%L$F<9$"2=6 >?@ 0?1D%-
-"DT%
19
Harison's internal medicine (Harrison's principles of internal medicine) Dennis Kasper; Anthony Fauci; Stephen Hauser; Dan Longo; J Jameson (McGraw-Hill Medical) update: 19th ed (2015) book structure & main content: 7 #:*+,*-!"),9C1%2 3 !3 -31"A , 45L$F<9 edition !9LBFA'(N1 2 volume -&6,%-B"P:5A Patient management algorithms /45 '(N1L12=%A?1D%-!"#D%-("P3% author:
=6 >'D)# D"B E;(F0 2+ 5+; F# 0%1310%:5A31"A , 45 G U'D6 >+2D"B'14 G53%L$F<9B= K20=6 >, F21310%:5A31"A , 45 '-6+D2F% eCHAPTERS -&6D%-,-O(, "1 H >AL$F<9 part !9'D6 >+ 2:05AD"B/2%&E)#(D$):5A-9BB$F%AU Content LBFA'(N1 19 parts Q ?1-F%AD%+ *#+31"A , 45'D%-2)1!) 7"+*-/ ,%'3$O:5AD%-'D)#*-/ L<9D% 6(-9D5BD%-B--+%+:5A*-/ C%/E12D 5+; F$F5!%D Part19 !9B5D -"DT% L<9&6C%8, 'D6 >+2D"B/F%E, J%/"P=%A/<)1)D Index 5+; F= 0%+'
how to use:
'()#$%& Index 5+; F= 0%+'
mental image: Diagnosis and Differential diagnosis
unique info: -!9'101K(=6 >D%-2)1! ) 7"+*-/ ,%'3$O:5AD%-'D)#
*-/ L<9D%--"DT% - '(N131"A , 45=6L8=+W, F21?3PF1)+&?@ 0D"1 '84 >5 ?@ 0'(N1L12=%A?1D%-2)1!) 7"+*-/ 20 > > >
Applied therapeutics author:
Brian K. Alldredge, et al (Lippincott Williams & Wilkins)
Update:
10th Ed (2012) book structure & main content:
31"A , 45LBFA section $%&D5+U '(N1D%-'-6+1 !%D case *#+3"2: 05?1L$F<9B=!9(-9D5B#02+ 1.Incidenc/prevalence/epidermiology 2.etiology 3.pathogenesis 4.clinical manifestation(sign&symptom) 5.Diagnosis (physical exam & laboratory test) 6(-9D5B#02+ mechanism :5A+%, Dosage regimen L<9 : 05L191IJ% 6.Treatment *#+!9&6$%-%A=F
:5A+%L$F<9$"2 how to use:
'()#!%D,%-B"P$%&B=/*-/ =6 >,1?! '()#!%D index # 0%13<"A31"A , 45 *#+31"A , 45'
mental image:
unique info: Disease for hospital with case-based learning G53%$%&*-/ -LBFA'14 -5M)B%+'14 G53%*#+=" >2K( L<95M)B%+?1&O&&5A:5A Case study
D%-=J%D-X6 R HDT% (,51EF%1D-X6 R HDT%)
21
Categorize ultimate question
""
Identification
456,B(792'/(0&13 >790 @@9,9 ! K9?456,B( ;62(#2=C-@9 ,.6%$( (1"9$ ( #2=C);,J:@9) A >629"F59@9.? !");1ME1@) ! MIMS (L A >629"F59 ! Physician desk reference ( L @9.? USA) !
! Drug
information handbook (with international trade name) ! Micromedex ! MIMs Thailand online "#
Availability !
3@946&O"&*@9$9( $ #NL
! Guideline
Pubmed 4 >5D%-/0%+%?1 (-9'=RK=+) ! MIMS ( @ 4 >5D%-/0%+% ! Physician desk reference ( @ ?1 USA) ! Drug information handbook (with international trade name) ! Micromedex !
"$
Pharmacokinetics Drug information handbook ! AHFS Drug information ! USP DI ! Drug Facts and comparison ! Uptodate ! Micromedex ! PubMed ! : 05&;
"%
Pregnancy/lactation
Drug in pregnancy and lactation ! Drug information handbook ! Uptodate ! Micromedex ! PubMed !
"&
Interactions Drug interaction facts ! Uptodate ! Micromedex ! Drug information handbook !
"'
Formulation !
Drug information handbook (extemporaneous
preparation) !
31"A , 45 extemporaneous :5A,&%/&'#ND?1-%@;(."&CW
! Remington
(knowledge)
"(
ADR/Side effect Drug information handbook !MEYLER's side effect of drugs ! USP DI vol1 ! Drug facts and comparison ! UpToDate ! Micromedex ! Pubmed -> case report !
")
Toxicity/Poisoning
!
A6@9H59?*+=) MB?@-*= + "9,9P (/? #&Q
! Drug
information handbook ! Micromedex ! UpToDate ! Pubmed ! Toxicology textbook
#*
Dosage/Administration Drug information handbook ! AHFS Drug information ! Drug facts and comparison ! Applied therapeutics ! UpToDate ! Micromedex ! Pubmed !
#!
Therapeutic use/Efficacy Guideline ! Pharmacotherapy (Dipiro) ! UpToDate ! Drug information handbook ! AHFS Drug information ! Drug facts and comparison ! Applied therapeutics !Micromedex ! Pubmed !
#"
Compatibility/Stability
Handbook on Injectable drug ! Micromedex ! Drug information handbook ! stability data 792$"+=1 # @9 !
##
Herbal/Conventional medicine Medplant ! Mosby's drug consult !
#$